Inspiratory Muscle Training in Patients With Autonomic Neuropathic
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study describes a controlled randomized clinical trial to evaluate the effect of inspiratory muscle training in patients with diabetic autonomic neuropathy.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetes Mellitus Diabetic Autonomic Neuropathy |
Other: Inspiratory muscle training (IMT) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Inspiratory Muscle Training in Patients With Autonomic Neuropathic: a Randomized Trial |
- Inspiratory muscle strength [ Time Frame: eight ] [ Designated as safety issue: Yes ]
- Variability of heart rate [ Time Frame: eight ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 24 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | July 2009 |
| Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
-
Other: Inspiratory muscle training (IMT)
- Diabetic autonomic neuropathy;
- Inspiratory muscle function testing;
- forced vital capacity and forced expiratory volume;
- Maximal functional capacity with incremental exercise test;
- variability of the heart frequency.
The diabetic autonomic neuropathy (NAD) is a common complication of diabetes mellitus (DM), both of the type 1 diabetes mellitus (DM1) as of the type 2 diabetes mellitus (DM2). The results of this study, would help to reveal the degree of commitment generated by NAD in respiratory muscle strength, can also enable the development of a new therapeutic approach, such non-pharmacological (respiratory muscle training), with a view to improve the respiratory muscle strength and alleviate the autonomic dysfunction in these patients.
Eligibility| Ages Eligible for Study: | 35 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diabetic autonomic neuropathy
- Age between 36 and
- 70 years old and signed in informed consent form
Exclusion Criteria:
- Presence of congestive heart failure
- Chronic obstructive pulmonary disease (FEV1 < 70% and/or FEV1%< 80
- Class II or III obesity (body mass index > 35)
Contacts and Locations| Contact: Beatriz D Schaan, MD, ScD | 555132303600 ext 3757 | beatrizschann@gmail.com |
| Brazil | |
| Institudo de Cardiologia do Rio Grande do Sul | Recruiting |
| Porto Alegre, RGS, Brazil | |
| Contact: Beatriz D Schann, MD, ScD 555132303600 ext 3757 beatrizschann@gmail.com | |
| Principal Investigator: | Beatriz D Schann, MD, ScD | Institudo de cardiologia de Porto Alegre |
More Information
No publications provided
| Responsible Party: | Organization: Intituto de Cardiologia do Rio Grande do Sul/ Fundação Universitária de Cardiologia, Beatriz Schann |
| ClinicalTrials.gov Identifier: | NCT00752440 History of Changes |
| Other Study ID Numbers: | 3865/06 |
| Study First Received: | September 12, 2008 |
| Last Updated: | September 15, 2008 |
| Health Authority: | Brazil: National Committee of Ethics in Research |
Keywords provided by Instituto de Cardiologia do Rio Grande do Sul:
|
Diabetes Mellitus Autonomic Neuropathy Inspiratory Muscle training |
Additional relevant MeSH terms:
|
Respiratory Aspiration Diabetes Mellitus Nervous System Diseases Diabetic Neuropathies Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Peripheral Nervous System Diseases Neuromuscular Diseases Diabetes Complications |
ClinicalTrials.gov processed this record on May 21, 2013